Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
Open Access
- 1 January 2020
- journal article
- editorial
- Published by Medknow in Asian Journal of Andrology
- Vol. 22 (3) , 233-235
Abstract
Asian Journal of Andrology,ChinaKeywords
This publication has 20 references indexed in Scilit:
- Benign prostatic hyperplasia: a new metabolic disease?Journal of Endocrinological Investigation, 2014
- Metabolic syndrome and prostate abnormalities in male subjects of infertile couplesAsian Journal of Andrology, 2014
- Risk Factors for Progression or Improvement of Lower Urinary Tract Symptoms in a Prospective Cohort of MenJournal of Urology, 2014
- Fat boosts, while androgen receptor activation counteracts, BPH‐associated prostate inflammationThe Prostate, 2012
- Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cellsJournal of Endocrinology, 2012
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone ProductionJAMA, 2012
- Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbitJournal of Endocrinology, 2011
- Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the REduction by Dutasteride of Prostate Cancer Events (REDUCE) TrialUrology, 2011
- Serum sex hormones and the 20‐year risk of lower urinary tract symptoms in community‐dwelling older menBJU International, 2010
- Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention TrialAmerican Journal of Epidemiology, 2008